Founded
Address
Polaris Venture Partners Inc
1000 Winter Street
Suite 3350
Waltham, MA 02451
United States
Phone
Website
Recent investment activity
Tags
KANDO id: 31159
Corporate information
Official name
Polaris Venture Partners Incorporated
Registration country
Company type
Multistage venture capital investors with focus Technology, Healthcare and ConsumerFunding rounds
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 101 - 125 of 166Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
![]() |
Turntable.Fm Inc (turntable) | Social music platform that encourages hanging out with people and discovering music. | Series A | |||
![]() |
Ultreo Inc | Ultrasound toothbrushes company for consumers | N/A | |||
![]() |
Veracode Inc | Provider of the world’s leading Application Risk Management Platform. | N/A | |||
![]() |
Visterra Inc | A biotechnology company discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. | Series A | |||
![]() |
Wakonda Technologies Inc | Series A | ||||
![]() |
Xpressdocs | N/A | ||||
![]() |
170 Systems | Series A led the round | ||||
![]() |
480 Biomedical Inc | Series A | ||||
![]() |
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series F | |||
![]() |
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series E | |||
![]() |
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series C Initial investment | |||
![]() |
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series B Follow-on investment | |||
![]() |
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | Series A Initial investment | |||
![]() |
Acceleron Pharma Inc | Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. | N/A | |||
![]() |
Accordant Health Services Inc | N/A | ||||
![]() |
Acusphere Inc | Pharmaceutical firm developing porous micro-particle delivery systems. | N/A | |||
![]() |
Adimab LLC | Developer of a human antibody discovery platform in yeast. | Series D | |||
![]() |
Advanced Inhalation Research Inc | N/A | ||||
![]() |
Aepona Ltd | Aepona is a software platform pioneer and global market leader in bringing Mobile Intelligence to Cloud Computing. | Series C | |||
![]() |
Akamai Technologies Inc | Cloud-based services for optimizing web and mobile content and applications, online HD video, and secure commerce. | N/A | |||
![]() |
Alimera Sciences Inc | Biopharmaceutical company. | Series B Initial investment | |||
![]() |
AlphaBlox Corp Inc | N/A | ||||
![]() |
American Superconductor Corp | N/A | ||||
![]() |
Arsenal Medical Inc | Biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform. | Venture Follow-on investment | |||
![]() |
Arsenal Medical Inc | Biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform. | Venture |